PHARMA

GSK only has eyes for Hikma

GlaxoSmithKline (GSK) has rejected separate takeover bids from Rameda and Acdima for its Egypt arm, focusing instead on talks with…

Something went wrong. Please refresh the page and/or try again.

Now Playing
Now Playing
00:00
00:00